PTC Therapeutics Inc
PTCT
Market Cap$1.89B
Close$
$29.89
17.3% upside
Current Fair Value
17.3% upsideUndervalued by 17.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.89 Billion |
|---|---|
| Enterprise Value | $1.32 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-8.37 |
| Beta | 1.43 |
| Outstanding Shares | 76,608,030 |
| Avg 30 Day Volume | 657,560 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.02 |
|---|---|
| PEG | 34.17 |
| Price to Sales | 2.12 |
| Price to Book Ratio | -2.32 |
| Enterprise Value to Revenue | 1.41 |
| Enterprise Value to EBIT | -3.78 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | -0.37 |
Revenue Sources
No data
ESG Score
No data
About PTC Therapeutics Inc
CEO: Stuart Peltz